RIG012
Selleck Chemicals
SKU:E1777-5MG
Couldn't load pickup availability

RIG012 is an antagonist of ATPases used in studies of Viral Entry / Replication. In practice, this places the compound in experiments that measure host-pathogen interactions, entry mechanisms, and replication-associated responses in cell signaling, immunology, and inflammation models.
By blocking ATPases, RIG012 can be used to examine host-pathogen interactions, entry mechanisms, and replication-associated responses. The enzyme annotation adds relevance to enzyme-activity assays, substrate-conversion studies, and mechanism profiling, together with downstream-response mapping in the same experimental setting. In cell signaling, immunology, and inflammation models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.
Research Applications
- Target-focused assays involving ATPases
- Pathway perturbation studies connected to Viral Entry / Replication
- Receptor-blockade and ligand-competition studies
- Enzyme-activity assays, substrate-conversion studies, and mechanism profiling
Overall, RIG012 is appropriate when a defined chemical perturbant is needed to connect ATPases with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in cell signaling, immunology, and inflammation models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.
- Targets:
- ATPases
- Target Class:
- Enzyme
- Pathways:
- Viral Entry / Replication
- Research Area:
- Cell Signaling • Immunology • Inflammation • Infectious Disease
- CAS No.:
- 2642218-43-5
- Molecular Weight:
- 359.42
- Formula:
- C₂₃H₂₁NO₃
- Storage Temperature:
- -20°C
For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.
The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.